Elan Corporation

6099.T
Medical Care Facilities
2026/10/30 12:01 Updated
Market Cap: $281.8M (¥44.5B)
Stock Price: $4.66 (¥736)
Exchange Rate: 1 USD = ¥157.98

Fiscal Year Ending December 2026 Third Quarter Earnings Presentation Materials

Domestic business growth centered on CS sets and expanded overseas deployment, increase in operating profit for the nine months through 3Q and an expected upward revision to full-year forecast. Impact of rising costs expected to widen from 4Q onward, but price revisions will be implemented sequentially. New medium-term plan will promote growth investments with ROE of 25% as the lower bound.

Importance:
Page Updated: October 30, 2026
IR Disclosure Date: October 30, 2026

Key Figures

  • Revenue 60,800 million yen (Actual)
  • Operating Income 5,000 million yen (Consolidated Forecast)
  • Net Income Attributable to Owners of Parent 3,200 million yen (Full-year Forecast)

AI要約

Performance Overview

In the third quarter of the fiscal year ending December 2026, revenue expanded due to increased new contracts for CS sets. Overseas sales showed a declining trend, but operating income increased thanks to growth in domestic CS sets and enhancement of value-added services. The full-year performance forecast is on track as of 3Q, and profit improvement from revisions to accounting treatment for LIFTE (Rifte) contributed as well. The impact of rising costs is expected to widen from 4Q onward, but appropriate price revisions are being implemented.

Outlook and Capital Policy

Under the new medium-term management plan (2026-2028), the company will continue growth based on CS sets, pursue growth investments and M&A with ROE of 25% as the lower bound, aiming to balance capital efficiency and growth. Capital allocation plans to generate approximately 16 billion yen of cash inflows over three years, combining M&A, business investment, and dividends to return capital to shareholders.

Comparison of Full-year Guidance and Results

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Elan Corporation

Company overview · Stock price · Financial data · All IR

View company page →